Lawrence Klein - CBO & COO at CRISPR Therapeutics AG

Insider Transactions and Holdings

Entity Type
Individual
Role
Cbo & Coo
Stock Symbol
CRSP on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Lawrence Klein since 10/5/2023

Holdings reported by Lawrence Klein for CRISPR Therapeutics AG

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 26.8K $1.67M $62.50 Mar 14, 2022 Direct
Stock Option (Right to Buy) 46.2K Feb 18, 2022 Direct Common Shares
Restricted Stock Units 12.5K Aug 16, 2022 Direct Common Shares

Transactions reported by Lawrence Klein for CRISPR Therapeutics AG

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.